Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension.
about
Capsule Endoscopy for Portal Hypertensive EnteropathyExpression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor and its intervention by interleukin-10 in experimental hepatic fibrosisVEGF165 antisense RNA suppresses oncogenic properties of human esophageal squamous cell carcinoma.Upregulation of vascular endothelial growth factor by hydrogen peroxide in human colon cancer.Angiogenesis effect on rat liver after administration of expression vector encoding vascular endothelial growth factor DROC curves in evaluation of serum fibrosis indices for hepatic fibrosis.Field population-based blocking treatment of esophageal epithelia dysplasia.Influence factors of serum fibrosis markers in liver fibrosis.Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinomaPlasma endothelin in patients with endotoxemia and dynamic comparison between vasoconstrictor and vasodilator in cirrhotic patientsMechanism of exogenous nucleic acids and their precursors improving the repair of intestinal epithelium after gamma-irradiation in mice.Expression of liver insulin-like growth factor 1 gene and its serum level in patients with diabetesCholangiocytes and blood supply.Collagen-binding vascular endothelial growth factor attenuates CCl4-induced liver fibrosis in mice.DSA analysis of hepatic arteriovenous fistula concurrent with hepatic cancer and its clinical significance.Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell.
P2860
Q26773122-62CDE953-2EE2-4CBE-8B6E-70D666C4311CQ28580777-E78BB6D1-0208-4085-BBE2-10015EC0C05BQ30724216-C164326B-6246-421A-8D4E-434996F02312Q30724325-5F0CC48C-CEA3-486C-930B-F06BB0865FEDQ36178349-8D324ADF-11FA-40F3-9B24-0F39220026B7Q36308405-E0FBE994-B50A-46BF-85F7-A58474BC8877Q36308500-E047DCF3-2072-4F84-97CE-3336E6FB4991Q36308848-66F169D1-7E4A-4CF5-90FE-EC29B8F974EAQ36397210-CA49B0F9-FE3F-49C1-AEE5-B2DF3C78B43DQ36397285-E3789E37-4350-4562-B3E0-8B4A0D96CFEBQ36397716-3593AAC6-5560-4195-A9E2-AB53BB7A4EA6Q36474411-2988B996-4E32-4E35-9855-5964EA1EA14DQ36506488-28B82C59-A959-40D0-AF46-4D87BB309309Q37403606-37901C98-D08B-4D2D-AECD-88465F9A242FQ41840983-BB528DE2-3531-44BB-87B6-8A761C661831Q43159514-6F0D73B1-88D0-4483-91F8-649FFBF16843
P2860
Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Clinical implication of VEGF s ...... r without portal hypertension.
@ast
Clinical implication of VEGF s ...... r without portal hypertension.
@en
type
label
Clinical implication of VEGF s ...... r without portal hypertension.
@ast
Clinical implication of VEGF s ...... r without portal hypertension.
@en
prefLabel
Clinical implication of VEGF s ...... r without portal hypertension.
@ast
Clinical implication of VEGF s ...... r without portal hypertension.
@en
P2093
P2860
P1476
Clinical implication of VEGF s ...... r without portal hypertension.
@en
P2093
P2860
P304
P407
P577
1999-08-01T00:00:00Z